Skip to Main Content

Author Details

Qiuheng Zhang
University of California Los Angeles
2005
37
18
PMIDPaper TitleJournal TitlePublished Year
37527494Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.Transplantation2024
37527494Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.Transplantation2024
36944607Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.Transplantation2023
37749817Virtual Crossmatch: By Any Other Name.Transplantation2023
36944607Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.Transplantation2023
37749817Virtual Crossmatch: By Any Other Name.Transplantation2023
34464505The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.Am J Transplant2022
36038413Current donor selection strategies for allogeneic hematopoietic cell transplantation.Hum Immunol2022
36644348Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.Kidney Int Rep2022
34464505The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.Am J Transplant2022
36644348Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.Kidney Int Rep2022
36038413Current donor selection strategies for allogeneic hematopoietic cell transplantation.Hum Immunol2022
33293041Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study.Transplant Proc2021
33892986Challenges in the application of NGS in the clinical laboratory.Hum Immunol2021
33293041Safety and Efficacy of a Steroid Avoidance Immunosuppression Regimen in Renal Transplant Patients With De Novo or Preformed Donor-Specific Antibodies: A Single-Center Study.Transplant Proc2021
33892986Challenges in the application of NGS in the clinical laboratory.Hum Immunol2021
32185871Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside.Am J Transplant2020
32185871Discovery of non-HLA antibodies associated with cardiac allograft rejection and development and validation of a non-HLA antigen multiplex panel: From bench to bedside.Am J Transplant2020
33163713Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.Kidney Int Rep2020
33163713Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation.Kidney Int Rep2020
30844424Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.Hum Immunol2019
30738112Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.Hum Immunol2019
30844424Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: Report from the 17th International HLA and Immunogenetics Workshop.Hum Immunol2019
31147565Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.Sci Rep2019
30738112Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.Hum Immunol2019
31147565Integrate CRISPR/Cas9 for protein expression of HLA-B*38:68Q via precise gene editing.Sci Rep2019
28927645Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.Kidney Int2018
28927645Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation.Kidney Int2018
29962081Identification of an HLA-A null allele, HLA-A*33:129N.HLA2018
29962028A novel HLA-A null allele, HLA-A*66:28N.HLA2018
29916988Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.Transplantation2018
29858804Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA.Methods Mol Biol2018
29802085Clinical phenomapping and outcomes after heart transplantation.J Heart Lung Transplant2018
30997435Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies.Kidney Int Rep2018
29916988Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.Transplantation2018
29802085Clinical phenomapping and outcomes after heart transplantation.J Heart Lung Transplant2018
29858804Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA.Methods Mol Biol2018
29962081Identification of an HLA-A null allele, HLA-A*33:129N.HLA2018
29962028A novel HLA-A null allele, HLA-A*66:28N.HLA2018
30997435Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies.Kidney Int Rep2018
27818166New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.Hum Immunol2017
28727227Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.Pediatr Transplant2017
27818166New priorities: Analysis of the New Kidney Allocation System on UCLA patients transplanted from the deceased donor waitlist.Hum Immunol2017
28727227Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients.Pediatr Transplant2017
27048228Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.Pediatr Nephrol2016
27345243The importance of non-HLA antibodies in transplantation.Nat Rev Nephrol2016
27048228Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.Pediatr Nephrol2016
27798706Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples.PLoS One2016
27798706Application of High-Throughput Next-Generation Sequencing for HLA Typing on Buccal Extracted DNA: Results from over 10,000 Donor Recruitment Samples.PLoS One2016
27345243The importance of non-HLA antibodies in transplantation.Nat Rev Nephrol2016
  • 1 - 50 of 74

Recommended Authors

University of South Florida
Career Start Year 2010
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Hannover Medical School
Career Start Year 2004
Number of shared co-authors 1
Hollings Cancer Center, Medical University of South Carolina
Career Start Year 2001
Number of shared co-authors 1
Weill Institute for Neurosciences, University of California San Francisco
Career Start Year 1999
Number of shared co-authors 3
University of Maryland School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Medical University of Graz
Career Start Year 1996
Number of shared co-authors 2
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 0
Ulm University
Career Start Year 1995
Number of shared co-authors 0
Children's Hospital Oakland Research Institute
Career Start Year 1995
Number of shared co-authors 4
Center for Systems Immunology, Benaroya Research Institute
Career Start Year 1993
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 1992
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 0
University of Alberta
Career Start Year 1991
Number of shared co-authors 1
INSERM UMRS, University Paris Cite
Career Start Year 1990
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 1990
Number of shared co-authors 2
University of Oklahoma Health Sciences Center
Career Start Year 1990
Number of shared co-authors 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1987
Number of shared co-authors 0
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 0
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 0
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 0
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 2
Universite de Strasbourg
Career Start Year 1976
Number of shared co-authors 1
Wash Benaroya Research Institute at Virginia Mason
Career Start Year 1975
Number of shared co-authors 2
Emory University
Career Start Year 1974
Number of shared co-authors 0
Children's Hospital Oakland Research Institute
Career Start Year 1971
Number of shared co-authors 3
Monash University
Career Start Year 1958
Number of shared co-authors 1

Collaborators

University of California Los Angeles
Co-authored papers 31
University of California los angeles
Co-authored papers 5
Co-authored papers 4
Ronald Reagan university of california los angeles Medical Center
Co-authored papers 4
University of California Los Angeles
Co-authored papers 4
David Geffen School of Medicine at University of California los angeles
Co-authored papers 4
University of California Los Angeles, David Geffen School of Medicine
Co-authored papers 3
University of California Los Angeles
Co-authored papers 3
University of California los angeles
Co-authored papers 3
UC Davis Medical Center
Co-authored papers 3
Ronald Reagan university of california los angeles Medical Center Los Angeles CA.
Co-authored papers 3
Anthony Nolan Research Institute, Royal Free Hospital
Co-authored papers 2
McGill University
Co-authored papers 2
Co-authored papers 2
Ronald Reagan university of california los angeles Medical Center
Co-authored papers 2
University of California los angeles
Co-authored papers 2
David Geffen School of Medicine, University of California los angeles
Co-authored papers 2
BioCryst Pharmaceuticals
Co-authored papers 2
University of California los angeles
Co-authored papers 2
University of California los angeles
Co-authored papers 1
David Geffen School of Medicine
Co-authored papers 1
David Geffen School of Medicine.
Co-authored papers 1
National Center for Global Health and Medicine
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
David Geffen School of Medicine, University of California, Los Angeles Medical Center
Co-authored papers 1
Co-authored papers 1
National Center for Global Health and Medicine
Co-authored papers 1
David Geffen School of Medicine at university of california los angeles
Co-authored papers 1
Washington University in St. Louis School of Medicine
Co-authored papers 1
University of California davis
Co-authored papers 1